House Bill 6973
117th Congress(2021-2022)
Enhanced Access to Affordable Medicines Act of 2022
Introduced
Introduced in House on Mar 8, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6973
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Enhanced Access to Affordable Medicines Act of 2022
This bill specifies that the Food and Drug Administration may approve generic drugs with different labels than the brand-name versions if, among other requirements, the brand-name drug is subject to an active patent or exclusivity period and a revised label for the brand-name drug is approved within 90 days (rather than 60 days) of the expiration of the patent or exclusivity period.
March 8, 2022
Sort by most recent
03/09/2022
Referred to the Subcommittee on Health.
03/08/2022
Referred to the House Committee on Energy and Commerce.
03/08/2022
Introduced in House
Public Record
Record Updated
Mar 8, 2023 7:58:48 PM